Foldrx Pharmaceuticals
FoldRx Pharmaceuticals, Inc. engages in the discovery and development of disease modifying drug therapies for diseases of protein misfolding and amyloidosis. The companyТs pipeline includes a program in advanced clinical development to treat...
Founded in 2003
Homepage: http://www.foldrx.com/
Total money raised: $29M
Past
Founded in 2003
Homepage: http://www.foldrx.com/
Total money raised: $29M
02140
100 Acorn Park Drive
5th Floor
Cambridge
USA MA
5th Floor
Cambridge
USA MA
Phone: 617-252-5500
Updated on Jun 16, 2010
Foldrx Pharmaceuticals at CrunchBase
Richard Labaudinière President and CEOFoldrx Pharmaceuticals at CrunchBase
Past
September, 2010
Foldrx Pharmaceuticals was acquired by Pfizer
Pfizer To Acquire FoldRx Pharmaceuticals 
foldrx.com
June, 2010
Foldrx Pharmaceuticals raised $29M in unattributed round from Novo Ventures, Morgenthaler Ventures, HealthCare Ventures, Fidelity Biosciences, TPG Biotechnology Partners, Alta Partners, and Novartis Venture Funds
FoldRx banks $29M for neurodegenerative drug application 
fiercebiotech.com
2003
Foldrx Pharmaceuticals was founded in 2003